Zai Lab (ZLAB) Operating Income (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Operating Income of -$69.4 million for Q1 2026, down 23.22% year-on-year from -$90.4 million in Q1 2025, and little changed on a QoQ basis from -$69.4 million in Q4 2025.
Zai Lab (ZLAB) Operating Income (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Operating Income for 9 consecutive years, with -$69.4 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Income fell 23.22% year-over-year to -$69.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.5 million (up 9.55% YoY) and the FY2025 annual result came in at -$229.4 million, up 18.67% from the prior year.
- Operating Income steadied at -$69.4 million in Q1 2026 per ZLAB's latest filing, from -$69.4 million in the prior quarter.
- Over the last five years, Operating Income for ZLAB reached as high as -$48.8 million in Q3 2025 and fell as low as -$128.6 million in Q3 2022.
- A 5-year average of -$79.5 million and a median of -$70.3 million in 2024 frame the typical range for Operating Income.
- The largest YoY upside for Operating Income was 64.88% in 2022 against a maximum downside of 54.54% in 2022.
- Year by year, Operating Income stood at -$97.3 million in 2022, then decreased by 27.43% to -$124.0 million in 2023, then jumped by 45.24% to -$67.9 million in 2024, then fell by 2.23% to -$69.4 million in 2025, then advanced by 0.03% to -$69.4 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$69.4 million, -$69.4 million, and -$48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -69.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.39 Mn |
| Dec 31, 2025 | -69.41 Mn |
| Sep 30, 2025 | -48.82 Mn |
| Jun 30, 2025 | -54.90 Mn |
| Mar 31, 2025 | -56.31 Mn |
| Dec 31, 2024 | -67.89 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | -76.06 Mn |
| Mar 31, 2024 | -70.31 Mn |
| Dec 31, 2023 | -123.98 Mn |
| Sep 30, 2023 | -83.57 Mn |
| Jun 30, 2023 | -89.50 Mn |
| Mar 31, 2023 | -69.52 Mn |
| Dec 31, 2022 | -97.29 Mn |
| Sep 30, 2022 | -128.58 Mn |
| Jun 30, 2022 | -98.72 Mn |
| Mar 31, 2022 | -79.76 Mn |
| Dec 31, 2021 | -219.20 Mn |
| Sep 30, 2021 | -83.21 Mn |
| Jun 30, 2021 | -170.57 Mn |